IAPO launched it's first ever Briefing Paper, on the topic of plant-made pharmaceuticals, at the Conference on Plant-Made Pharmaceuticals, Montréal, Canada, 30 January - 2 February 2005.

The Briefing Paper provides accurate, independent information based on current evidence-based research to patients’ organizations and patient advocates worldwide to equip them with an understanding of the science, technology and related social, ethical, economic and environmental issues.

Albert van der Zeijden, IAPO Chair, commented: “Patients need to be well informed as to the existing and potential benefits and risks of emerging technologies which will affect them directly. We hope that making this information accessible to patients’ organizations worldwide will enable them to make an informed judgement on the possible value of PMPs to the patients they represent and to engage in debate and policy-making.”

“IAPO’s Paper is an important examination of PMPs that for the first time examines the technology from the point of view of the patient,” said François Arcand, conference organizer and president of Canada’s Society for Moleculture. “We are honoured that IAPO has chosen to present its findings at our event.”

IAPO is distributing this Briefing Paper to patients’ organizations on its database free of charge in January 2005. If you represent a patients’ organization and would like to receive future IAPO mailings and publications, please complete this form and fax to +44 20 7721 7596 or email your contact details to info@patientsorganizations.org.

Read Press Release of 12 January 2005

Read Press Release of 12 January 2005 (PDF)

The Briefing Paper is available to other organizations and companies for a small charge of $30 (non-profits) or $60 (for-profits). Download the Order Form (PDF format), complete and fax it to +44 20 7721 7596.